Skip to main content
Clinical Trials/NCT04527393
NCT04527393
Completed
Phase 4

Effects of Individualized Opioid Analgesia Versus Conventional Opioid Analgesia After Adenotonsillectomy in Children

Children's Hospital of Fudan University1 site in 1 country542 target enrollmentMay 1, 2022

Overview

Phase
Phase 4
Intervention
Individualized oral morphine
Conditions
Adenotonsillectomy
Sponsor
Children's Hospital of Fudan University
Enrollment
542
Locations
1
Primary Endpoint
Desaturation events
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The objective of this randomized clinical trial is to assess the safety and effectiveness of post-adenotonsillectomy analgesia with individualized opioid analgesia regime in children.

Detailed Description

Patients will be randomly assigned to individualized opioid analgesia regimen group or conventional opioid analgesia regimen group. Intravenous 1μg/kg fentanyl is administered as a test in patients with spontaneous breath after sevoflurane induction. A positive result is defined as a decrease of more than 50% in spontaneous respiratory rate (rate after fentanyl test versus rate before fentanyl test). Otherwise it is defined as a negative result. All the patients are given regular paracetamol and ibuprofen after surgery. The addition of rescue oral morphine is given as needed. The dose of oral morphine is determined according to the results of fentanyl test in the individualized group, while the patients in the conventional group are given the routine dose. The Faces Scale is used to assess analgesic effectiveness by parents from postoperative day 1 to day 10. If the Faces Scale score \> 6, the child receive rescue oral morphine analgesia. At the preoperative appointment, parents are provided with a pulse oximeter including oxygen saturation sensors to take home. The oxygen saturation per night during sleep will be monitored using the pulse oximeter by parents from postoperative Day 1 to Day 10. The research team will instruct parents on how to properly apply the oximeter to the child and repeat these measurements. The primary outcome measure is desaturation events during sleep per night.

Registry
clinicaltrials.gov
Start Date
May 1, 2022
End Date
January 10, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Children, ASA physical status I or II, who is scheduled to undergo adenotonsillectomy will be recruited.

Exclusion Criteria

  • Children with craniofacial deformities, neuromuscular diseases, mental retardation, body mass index \> 30kg/m2 , or a recent history of opioid use are excluded.

Arms & Interventions

individualized opioid analgesia regimen group

The dose of oral morphine for patients in the individualized group is determined according to the results of fentanyl test.

Intervention: Individualized oral morphine

conventional opioid analgesia regimen group

Patients in the conventional group are given routine dose of oral morphine.

Intervention: Conventional oral morphine

Outcomes

Primary Outcomes

Desaturation events

Time Frame: from postoperative day 1 to day 10, each night

The oxygen saturation per night during sleep will be monitored using a pulse oximeter by the parents from postoperative Day 1 to Day 10. The research team will instruct parents on how to properly apply the oximeter to the child and repeat these measurements. The primary outcome measure is desaturation events during sleep per night.

Secondary Outcomes

  • Scores of Pain Scale (the Faces Scale)(every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day))
  • Scores of Pain Scale (the Objective Pain Scale)(every four hours from postoperative Day 1 to Day 10 (eg: 8:00, 12:00, 16:00, and 20:00, each day))
  • Tonsillar bleeding events(from postoperative day 1 to day 10)
  • Adverse drug reactions(from postoperative day 1 to day 10)

Study Sites (1)

Loading locations...

Similar Trials